The facts of the case revolved around whether Pom could make specific health claims about its pomegranate juice including that it can treat or reduce the risk of diseases such as prostate cancer without prior approval from FTC for each such claim made . The FTC argued that even though some scientific studies showed them to be true ,they did not meet the level scrutiny required by law so as deemed reliable enough warrant being used marketing purposes and thus should not have been used at all in light thereof. The issue before the court was whether or not Pom had violated Section 5 of the FTC Act which requires companies to possess scientific evidence to support their product health claims when making them publicly available; if they lack said evidence then those further proceedings might taken place accordingly thereto. During reasoning analysis Court determined that there existed sufficient evidence showing efficacy certain health related treatments associated with use POM products yet this alone did not necessarily mean they needed approved by FTC first order market same since other factors such as degree trustworthiness associated data collected during research processes needed taken into account when assessing overall effectiveness any given statement/claim made .Therefore Court ultimately held favor FEC ruling against POM stating that although some evidence existed supporting same fact remained still need substantiated more thoroughly order deemed reliable whatsoever based on current standards law.< br >In conclusion The D.C Circuit upheld the decision made by the Federal Trade Commission finding it reasonable under existing laws governing such matters meaningfully concluding case herewith simultaneously providing guidance applicable field moving forward likewise

Sample Solution

Pom Wonderful LLC v. Federal Trade Commission, 793 F.3d 1016 (D.C Cir 2015) was a case in which Pom Wonderful LLC (“Pom”), a company that makes and markets pomegranate-based products, appealed the decision of the Federal Trade Commission (FTC) which found that Pom’s advertising claims regarding its antioxidant health benefits were false and unsubstantiated.